SEPTInvestingStart Free

ERNA SCHEDULE 13G/A: SEC filing

Bleichroeder LP

Filed with the SEC on · accession 0001420506-26-002563

ERNA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.2% by the first close after the filing.

Summary of the filing

Bleichroeder LP filed an amended Schedule 13G reporting beneficial ownership of 80,000 common shares, or 4.67%, of Ernexa Therapeutics Inc. as of September 30, 2026, held in its capacity as a registered investment adviser for various clients.

For details, click here →

Key details

Common shares beneficially owned$80K
Percent of class beneficially owned$5
Reporting person / investment adviser holding 4.67% of common sharesBleichroeder LP
Reporting person / parent holding companyBleichroeder Holdings LLC
Issuer of the securitiesErnexa Therapeutics Inc.
President and ceoAndrew Gundlach

How ERNA stock reacted

Close before

$2.02

Nov 9, 2026

First close after

-0.25%

$2.01

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ERNA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ERNA?

Click here

Frequently asked questions

What did ERNA file with the SEC on Nov 10, 2026?

ERNA filed a SCHEDULE 13G/A (SEC filing). Bleichroeder LP filed an amended Schedule 13G reporting beneficial ownership of 80,000 common shares, or 4.67%, of Ernexa Therapeutics Inc. as of September 30, 2026, held in its capacity as a registered investment adviser for various clients.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ERNA stock react to this filing?

ERNA closed at $2.02 before the filing and $2.01 on Nov 10, 2026 (-0.25%).

Other ERNA SEC filings

Get alerts when ERNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ERNA overviewERNA analysisERNA newsLatest SEC filings